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Summary
Background: The Drosophila archipelago gene (ago) encodes
the specificity component of a ubiquitin ligase that targets the
cyclin E and dMyc proteins for degradation. Its human ortho-
log, Fbw7, is commonly lost in cancers, suggesting that failure
to degrade ago/Fbw7 targets drives excess tissue growth.
Results: We find that ago loss induces hyperplasia of some
organs but paradoxically reduces the size of the adult eye.
This reflects a requirement for ago to restrict apoptotic activity
of the rbf1/de2f1 pathway adjacent to the eye-specific mor-
phogenetic furrow (MF): ago mutant cells display elevated
de2f1 activity, express the prodeath dE2f1 targets hid and
rpr, and undergo high rates of apoptosis. These phenotypes
are dependent on rbf1, de2f1, hid, and the rbf1/de2f1 regula-
tors cyclin E and dacapo but are independent of dp53. A trans-
activation-deficient de2f1 allele blocks MF-associated apo-
ptosis of ago mutant cells but does not retard their clonal
overgrowth, indicating that intact de2f1 function is required
for the death but not overproliferation of ago cells. Epidermal
growth factor receptor (EGFR) and wingless (wg) alleles also
modify the ago apoptotic phenotype, indicating that these
pathways may modulate the underlying sensitivity of ago
mutant cells to apoptotic signals.
Conclusions: These data show that ago loss requires a collab-
orating block in cell death to efficiently drive tissue overgrowth
and that this conditional phenotype reflects a role for ago in re-
stricting apoptotic output of the rbf1/de2f1 pathway. More-
over, the susceptibility of ago mutant cells to succumb to
this apoptotic program appears to depend on local variations
in extracellular signaling that could thus determine tissue-
specific fates of ago mutant cells.
Introduction
Genetic screens in the fruit fly Drosophila melanogaster have
identified many genes that restrict growth of developing tissues
(reviewed in [1, 2]). In some cases, orthologs of theseDrosophila
growth suppressor genes have subsequently been implicated
as vertebrate tumor suppressors. One example is the archi-
pelago (ago) gene, which was identified because agomutations
confer a growth advantage to imaginal disc cells [3]. ago
encodes an F box/WD (tryptophan/aspartic acid) protein (Ago)
that acts as the substrate adaptor for an Skp/Cullin/F box
(SCF) E3 ubiquitin ligase. SCF-Ago targets the G1/S cell-cycle
regulator cyclin E (CycE) and dMyc, the fly ortholog of the
*Correspondence: kmoberg@cellbio.emory.educ-Myc proto-oncogene, for degradation in vivo [3, 4]. These
proteins hyperaccumulate in ago mutant cells and drive
balanced increases in rates of division and growth, producing
enlarged clones composed of normally sized cells [4]. In addi-
tion to this mitotic role, ago also regulates hypoxia sensitivity
and postmitotic morphogenesis of the tracheal system via
degradation of the Trachealess transcription factor [5, 6].
Fbw7, the human ago ortholog, is frequently mutated in a
wide array of human tumor types, including those of endome-
trial, colorectal, and hematopoietic origin (reviewed in [7]).
Moreover, deletion of murine Fbw7 increases cancer inci-
dence and collaborates with p53mutations to promote epithe-
lial carcinogenesis [8]. Growth suppression by Fbw7 is linked
to defective degradation of SCF substrates including CycE,
c-Myc, the Notch intracellular domain, c-Jun, sterol regulatory
element-binding protein (SREBP), and mTor kinase (reviewed
in [7, 9]). Thus, ago and Fbw7 both behave as antigrowth genes
in vivo, and this property derives in part from their role in the
timely destruction of common oncogenic substrates like
CycE and Myc.
Many Drosophila mutations that accelerate the rate of cell
proliferation also increase the size of the corresponding adult
organ. Such mutations affect various regulatory networks,
including the Tsc/Tor, IGF/PI3K, Sav/Wts/Hpo, ras/EGFR,
and Notch pathways (reviewed in [1, 2]). Notably, ectopic
expression of progrowth factors such as dMyc in larval discs
also increases adult organ size [10]. It is therefore somewhat
surprising that adult eyes composed mainly of ago mutant
cells expressing very high levels of dMyc are not obviously
enlarged [3, 4]. One explanation for this might be that excess
dMyc causes ago cells to behave as ‘‘supercompetitors’’
that kill adjacent normal cells [11, 12], thus balancing the over-
all rate of growth of a mosaic organ. Alternately, an as yet
unrecognized cell-autonomous mechanism might limit the
ability of ago mutant cells to give rise to an enlarged organ.
Here, we uncover a requirement for ago to maintain eye size
that reflects a cell-autonomous role for ago upstream of the
rbf1/de2f1 pathway in cells just anterior to the eye-specific
morphogenetic furrow (MF). ago mutant cells fail to downregu-
late de2f1-dependent transcription, express elevated levels of
prodeath dE2f1 target genes, and undergo high rates of apo-
ptosis. Blocking this death causes ago mutant discs to grow
into enlarged adult eyes, indicating that ago loss requires
a collaborating antiapoptotic event to drive eye hypertrophy.
agoapoptotic phenotypes are also sensitive toEGFRandwing-
less signaling, indicating that extracellular pathways can alter
the threshold for e2f1-driven death of ago mutant cells. These
data identify ago as a required upstream regulator of the rbf1/
de2f1 pathway in eye disc cells and show that apoptosis medi-
ated by this pathway can act as a significant brake on the
growth of developing tissues lacking theago tumorsuppressor.
Results
Loss of ago Has Different Effects on the Size of Tissues
in the Adult Head
Drosophila with eyes and heads composed almost entirely of
ago mutant tissue were generated with the ago1 allele and
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mutation to kill M/M cells, allowing ago1/ago1 cells to populate
the disc and adult structures derived from it. ago1 encodes
a prematurely truncated protein that cannot bind CycE and
dMyc and increases levels of these proteins in vivo [3, 4].
Thus, the ago1/M(3) genotype provides a model of organ de-
velopment in the absence of normal ago activity. Adult ago1/
M(3) eyes were smaller than control eyes (Figures 1A and
1B). This phenotype was specific to the eye: other organs in
ago1/M(3) heads, such as the antennae (arrows, Figures 1A
and 1B) and interocular cuticle, grew larger. A similar effect
was observed with other ago alleles (data not shown). Thus,
although ago behaves as a growth suppressor in some
tissues, it is required for the developing eye to reach its normal
size.
Eye development is uniquely dependent on the MF, a moving
compartment boundary that sweeps posterior to anterior
across the larval disc and separates it into areas: asynchro-
nously dividing cells anterior to the MF, G1 phase-arrested
cells within the MF, and largely postmitotic cells posterior to
the MF [14]. ago loss did not substantially alter the pattern of
S phase entry in the vicinity of the MF (see Figure S1 available
online), but it did produce an intense ‘‘stripe’’ of apoptosis, as
detected with an antibody to the cleaved form of caspase-3
(C3), that extended laterally across the entire third-instar eye
disc (Figures 1C and 1D). A second ago allele, ago3 [3], pro-
duced a similar pattern of apoptosis (Figure S2). Costaining
for C3 and Atonal protein, which marks cells within the MF
[15–17], showed that this death extended w5–10 cell diame-
ters from the anterior edge of the MF into the anterior portion
of the disc (Figure 1E). This pattern was strongest at the lateral
margins of ago1/M(3) eye discs but was still penetrant enough
to appear as a contiguous stripe in medial areas. Notably, C3
was also detected in ago1 clones that crossed the MF (see
below), indicating that this apoptosis is autonomous to ago
cells and not a product of the cell-lethal technique used to
generate ago1/M(3) discs. Thus, in addition to its growth
suppressor function, ago is also required to protect cells
from death in a region just anterior to the MF.
Figure 1. ago Loss Reduces Eye Size and Elevates Apoptosis
(A and B) Images of FRT80B/M(3) (A) and ago1/M(3) (B) adult female heads.
Black bar denotes depth of FRT80B/M(3) eyes. Arrows indicate increased
antenna size in ago1/M(3) heads.
(C–E) Merged confocal sections of FRT80B/M(3) (C) and ago1/M(3) (D and E)
larval eye-antennal discs stained for C3 or Atonal as indicated. Arrowheads
indicate position of the morphogenetic furrow (MF). In these and all
following images, posterior is to the left.
Blocking Death Increases ago Mutant Eye Size
The C3 data suggest that the MF is preceded by an intense
wave of cell death that culls many cells from developing
ago1/M(3) eyes. To test whether blocking this could reverse
the ago small-eye phenotype, the ago1 allele was combined
with the Df(3)H99 genomic deletion, which removes the proa-
poptotic genes rpr, grim, and hid [18]. This completely blocked
the C3 stripe (compare Figures 2A0 and 2B0) and produced
adult heads that were much larger than ago1/M(3) or H99/
M(3) heads (compare Figures 2A and 2B). H99/M(3) heads
were similar in size to control FRT80B/M(3) heads (see below
and data not shown). Thus, the ago1 and H99 mutations coop-
eratively increase organ size. This effect was apparent in other
head organs as well (e.g., antennae in Figure 2 and Figure S3).
Combining ago1 and the hid05014 allele [19] was also sufficient
to block C3 accumulation and increase organ size (Figures 2C
and 2C0; Figure S3). Together, these data indicate that hid- and
H99-dependent apoptosis of ago1 mutant cells restrains the
oncogenic effect of ago loss in multiple tissues and that in
the larval eye, this death is concentrated in an area just anterior
to the MF.
ago Mutations Elevate dE2f Activity in the Furrow
ago MF-associated apoptosis resembles the pattern of death
among cells lacking the Drosophila retinoblastoma (Rb) gene
homolog rbf1 [20], suggesting that these genes function within
a common antiapoptotic pathway in cells just anterior to the MF.
Like mammalian Rb,Rbf1 binds to thedE2f1 transcription factor
and inhibits the expression of dE2f1 target genes (reviewed in
[21]). This inhibition is reversed by G1 cyclin-dependent kinases
that phosphorylate Rbf1 and dissociate it from dE2f1, allowing
dE2f1 to transactivate target gene promoters. rbf1 mutations
thus upregulate expression of dE2f1 targets, including PCNA
[22] and the proapoptotic genes hid [23] and rpr [24], which
leads to MF-associated death of rbf1 mutant cells [20].
To test whether ago controls de2f activity in the eye, we
placed the dE2f reporter transgene PCNA-GFP [25] into the
background of ago1 mosaic eye discs (Figure 3C). dE2f1 pro-
tein levels normally increased in cells just anterior to the MF
(Figures 3A and 3A0), presumably as a result of a require-
ment for dE2f1 in Rbf1-mediated transcriptional repression.
Figure 2. Blocking Death of ago Cells Produces Enlarged Organs
ago1/M(3) (A), agox2,Df(3L)H99/M(3) (B), and ago1,hid05014/M(3) (C) adult
female heads and merged confocal sections of a-C3 staining in correspond-
ing larval eye discs (A0–C0). Black bar is standardized to the depth of ago1/
M(3) eyes; arrows indicate increased antennal size. Arrowheads indicate
position of the MF.
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in wild-type areas of mosaic eye discs (Figures 3C–3C00; blue
bracket denotes MF). By contrast, PCNA-GFP expression in
ago1 clones was elevated in the region just anterior to the
MF (denoted by red bracket) and within the MF (Figure 3C0).
The elevatedPCNA-GFP expression just anterior to the MF ap-
peared to correlate spatially with the location of C3 expression
in ago1 cells. RNAi depletion of ago also activated the dE2f-
responsive reporter PCNA-luc in S2 cells (Figure 3B), although
this was not associated with high rates of apoptosis (data not
shown). The magnitude of the effect on PCNA-luc expression
was less than that produced by directly targeting rbf1 with
double-stranded RNA (dsRNA) interference, consistent with
the idea that ago loss inactivates Rbf1 indirectly through inter-
mediate factors. Because ago mutations do not change
patterns of dE2f1 protein expression in discs (S.C.N. and
K.H.M., unpublished data), they appear to derepress the
Figure 3. ago Restricts dE2f Activity
(A and A0) Merged confocal sections of an eye disc stained for Elav (blue)
and dE2f1 (red) showing increase in dE2f1 levels anterior to and within the
MF (arrowhead).
(B) Relative luciferase activity in S2 cells transfected with PCNA-luc and
double-stranded RNAs (dsRNAs) corresponding to the white, ago, or rbf1
genes. Error bars represent the standard deviation of the mean. *p < 0.05.
(C–C00) PCNA-GFP expression (blue) in ago1 mutant clones marked by
absence of b-galactosidase (red). GFP expression in ago clones (outlined
in C) anterior to the MF is indicated with arrows in (C0). In (C0), blue bracket
denotes MF; red bracket denotes area just anterior to MF.
(D and E) Expression of dap reduces MF-associated death in ago1/M(3)
discs. Arrowheads indicate position of the MF.existing pool of dE2f1 protein. Together, these observations
indicate that agomutations deprive cells of an important check
on dE2f1 and suggest that this might activate an MF-associ-
ated apoptotic program similar to that elicited by loss of rbf1.
Because CycE hyperaccumulates in ago mutant cells
throughout the eye disc [3] and acts upstream of de2f1
(reviewed in 21]), CycE-associated kinase activity might con-
tribute to ago1 MF-associated apoptosis. To test this hypoth-
esis, we expressed the CycE/cdk2 inhibitor dacapo ubiqui-
tously in ago1/M(3) discs. This reduced C3 staining (Figures 3D
and 3E), particularly toward the lateral edges of the disc.
Reciprocally, expression of either cycE or dMyc in otherwise
normal larval eye discs was able to induce ectopic apoptosis
anterior to the MF (Figure S4). Thus, elevated expression of
two SCF-Ago targets is sufficient to elevate rates of apoptosis
just anterior to the MF; moreover, the activity of one of these
proteins, CycE, appears to be necessary for the ago MF-asso-
ciated apoptotic phenotype.
de2f1 and rbf1 Control Apoptosis of ago Cells
To directly test whether de2f1 is required for the MF-associ-
ated death of ago cells, we used the de2f1i2/rM729 viable allele
combination to reduce de2f1 activity in the background of ago
mosaic eye discs (Figure 4). de2f1rM729 is an amorph [26],
whereas de2f1i2 is a hypomorph that lacks the activation
domain and Rbf1-binding motif [27]. The de2f1i2/rM729 allele
combination has no residual dE2f1 trans-activation function
but supports normal patterns of division and MF progression
in the eye disc [20]. MF-spanning ago clones accumulated
high levels of C3 (Figures 4A–4A00) (as noted previously [3],
the ratio of mutant to normal tissue in the ago mosaic larval
eye is less than that observed in the adult eye, indicating
that the ago growth advantage arises progressively during
eye development), but C3 was absent from ago1 clones in
the de2f1i2/rM729 background (Figures 4B–4B00). Residual C3
was sometimes detected in lateral areas of these discs
(compare Figure 2B0 and Figure 4B0), suggesting that death
of ago1 cells in this area is not as dependent on de2f1 as it is
in more central regions. Expression of rbf1 in ago1/M(3) discs
was also able to substantially reduce the MF-associated C3
stripe (Figure 5). Thus, reducing de2f1 activity, either by
elevating levels of rbf1 or by removing the de2f1 trans-acti-
vation function, blocks death of ago1 cells. Interestingly,
although de2f1i2/rM729 animals were proportionately smaller
than de2f1+ animals, ago1 mosaic eyes generated in the
de2f1i2/rM729 background showed a strong white:red ratio
that was at least comparable to the white:red ratio of ago1
mosaic eyes (Figures 4C–4D0). Thus, transactivation by dE2f1
is not required for the clonal growth advantage of ago1 cells.
Rather, the evidence suggests that the main effect of elevated
de2f1 activity in ago1 cells is to promote apoptosis, particularly
in cells lying just anterior to the MF.
The somewhat paradoxical finding that expression of rbf1
might increase cell number by rescuing the death of ago1 MF
cells prompted a closer examination of the relationship be-
tween ago1 eye size and gene dosage of G1/S regulatory
factors. Eye size was determined by normalizing the two-
dimensional en face area of the eye to the area between the
L3, L4, and posterior cross-veins (Figure 6). This technique
does not take into account bulging out of the surface of the
eye and can underrepresent increases in eye size (e.g., ago1,
hid05014/M(3) eyes were slightly larger than FRT80B/M(3)
controls in an en face view [Figure 6C] but were much larger
than FRT80B/M(3) in head-on views [Figure S3]). Nonetheless,
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increased ago1/M(3) eye size (Figures 6A–6C). A similar effect
is observed with a null allele of cyclin E (cycEAR95; [28]). Thus,
loss of ago creates a situation in which G1/S factors that
normally promote the growth of wild-type organs become
dosage-sensitive inhibitors of growth. Alleles of cdk4 (Fig-
ure 6C) and dMyc (data not shown) also dominantly increased
ago1/M(3) eye size but simultaneously increased adult wing
size, so that the final eye:wing ratio was unchanged. Because
de2f1 is required for apoptosis of ago1 eye cells, these data are
consistent with a model in which reducing the dose of de2f1
and cycE restores their activities to levels that are permissive
for proliferation but reduce apoptosis. This phenomenon
might be the invertebrate correlate of the ‘‘E2F threshold’’
hypothesis, in which the effect of E2F on cell number is postu-
lated to depend on a hypothetical threshold of activity below
which E2F promotes cell cycling and above which it becomes
proapoptotic [29].
Relationship between ago and Apoptotic Regulators
E2F-driven cell death can occur by pathways that are either
dependent on or independent of the p53 transcription factor
Figure 4. de2f1 Transactivation Is Required for Apoptosis but Not for the
Proliferative Advantage of ago Mutant Cells
(A–B00) Merged confocal sections of ago1 clones marked by the absence of
GFP(green) generated in wild-type (A–A00) orde2f1i2/rM729mutant (B–B00) back-
grounds and stained with a-C3 (blue). Arrowheads indicate the MF; arrows in
(A0) indicate C3 signal in ago clones that span the MF. Note the absence of C3
signal in ago mutant clones that span the MF in de2f1i2/rM729 discs.
(C–D0) Paired views of eyes and heads from ago1 mosaic (C and C0) or ago1
mosaic+de2f1i2/rM729 (D and D0) adult females in which ago1 mutant tissue is
marked by the absence of red pigment; the white:red imbalance persists in
the de2f1i2/rM729 background. Reduced organ size in (D) and (D0) is a result
of the effect of the de2f1i2/rM729 genotype on organism size.(reviewed in [30]). Expression of a dominant-negative form of
Drosophila p53 (UAS-dp53R155H; [31]) did not block C3 accu-
mulation in ago1 cells (Figure S5). e2f1-driven death of ago1
Figure 5. Excess rbf1 Suppresses the Cell Death of ago Mutant Cells in the
Morphogenetic Furrow
ago1/M(3) (A) and ago1/M(3),eyGal4,UAS-rbf1 (B) eye discs stained for Elav
(red) and C3 (blue) to mark dying cells. Arrowheads indicate position of
the MF.
Figure 6. Modification of ago Eye Size by Cell-Cycle Regulators and
Signaling Components
(A and B) Light microscopic images of ago1/M(3) (A) and ago1/
M(3),de2f1rM729/+ (B) adult female eyes. Note that the eye in (B) is larger.
(C) Graphic summary of the effect of the indicated genotypes on en face
adult female eye size. Wing areas were measured between the L3 and L4
veins and the posterior crossvein. Error bars represent 95% confidence
intervals.
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can be reversed by elevating expression of rbf1 or by removing
the dE2f1 target gene hid. hid and rpr, which is also inducible
by dE2f1 [24], were both overexpressed in ago1/M(3) eye discs
(Figures 7A and 7B), and Hid and Rpr proteins accumulated in
ago1 clones that overexpressed the antiapoptotic gene p35
(Figures 7C–7D00). This effect occurred anterior to the MF, but
also in posterior areas of the eye disc. The MF-associated
Hid accumulation seemed to be slightly more anterior relative
to the MF than the C3 stripe, consistent with a delay between
Hid expression and C3 buildup. Notably, not all ago1+p35 cells
in the area anterior to the MF accumulated Hid and Rpr, indi-
cating either that these proteins accumulate transiently in
ago1 cells even in the presence of p35 or that additional factors
are limiting for their expression. Together, these molecular
data indicate that ago1 MF-associated apoptosis requires
the de2f1 transactivation domain and transcription of the
de2f1 targets hid and rpr.
The prosurvival activity of the epidermal growth factor
receptor (EGFR) receptor tyrosine kinase (RTK) is linked in
part to its ability to inhibit hid [32, 33], and this function is
proposed to underlie a prosurvival role for EGFR in rbf1mutant
MF cells [20]. Given that ago acts upstream of the de2f1
pathway and hid, we sought to determine whether the death
of ago1 cells also proceeds by an EGFR-sensitive mechanism.
eyGal4-driven expression of the EGFREllipse gain-of-function
allele (Elp) [34] blocked MF-associated C3 in ago1/M(3) discs
(Figures 8A and 8A0) and synergized with ago1/M(3) to increase
Figure 7. hid and rpr Expression Are Elevated in ago Mutant Tissue
(A and B) Quantitative real-time PCR analysis of the expression of hid (A) and
rpr (B) mRNAs in FRT80B/M(3) control and ago1/M(3) eye antennal discs.
hid mRNA was also measured in ago1/M(3),eyGal4,UAS-p35 discs in order
to prevent the loss of hid mRNA in dying cells. Error bars represent the stan-
dard deviation of the mean.
(C–D00) ago1 clones, marked by the absence of b-galactosidase (red), in
eyGal4,UAS-p35 discs stained with a-Hid (C–C00) or a-Rpr (D–D00) (both
blue in C and D). Opposing arrowheads indicate the MF. Arrows indicate
accumulation of Hid or Rpr in ago1 clones.disc size (Figure 8B). Elav expression was normal in this geno-
type, indicating that C3 loss is not an indirect result of MF loss.
C3 signal in posterior areas of ago1/M(3)+ey > Elp discs was
also observed in ey > Elp discs (data not shown), indicating
that it occurs independently of ago1. In the reciprocal experi-
ment, EGFR activity was reduced in ago1/M(3) discs with the
EGFRt1 hypomorphic allele [35]. This dramatically shrank
ago1/M(3) adult eyes (Figure 6C). A similar effect was observed
with a second allele, EGFRf24 (data not shown). These data
indicate that ago1 sensitizes eye cells to reduced EGFR
signaling. To further test the interaction between EGFR/RTK
signals and ago, C3 expression was tested in eye discs doubly
mutant for ago and the EGFR inhibitors Gap1 (Gap1F2.4-A3;
K.H.M. and I.K. Hariharan, unpublished data) or argos (aosD7;
[36]) or the RTK inhibitor sprouty (styD5; [37]). Whereas each
of these alleles is able to rescue rbf1 cell death in the MF
[20], they were not equally capable of rescuing the death of
ago1 MF cells (Figures 8C–8E): styD5 largely blocked C3 accu-
mulation, with two areas of C3 remaining laterally (Figure 8C),
whereas neither Gap1F2.4-A3 nor aosD7 detectably altered the
pattern of C3 accumulation (Figures 8D and 8E). Because
aosD7 rescues the death of rbf1 mutant MF cells [20], these
data argue that, although MF-associated apoptosis of ago1
and rbf1 cells is similar in that they both require de2f1,
ago1 cells require stronger EGFR/RTK signals (i.e., styD5 and
Figure 8. Death of ago Mutant Eye Cells Is Sensitive to Extracellular
Signaling Pathways
(A and A0) Merged confocal sections of ago1/M(3) discs generated in a back-
ground overexpressing the hyperactive EGFRElp allele (eyGal4,UAS-Elp)
stained for Elav (red) or C3 (blue) to mark dying cells. Arrowheads indicate
position of the MF.
(B) Light microscopic images of eyGal4,UAS-Elp and ago1/M(3),eyGal4,
UAS-Elp discs. (The ago1/M(3),eyGal4,UAS-Elp genotype is pupal lethal
and could not be included in the analysis in Figure 6C.)
(C–F) Merged confocal sections of ago1,styD5/M(3) (C), ago1,aosD7/M(3) (D),
ago1,Gap1F2.4-A3/M(3) (E), andwgl-17/+;ago1/M(3) (F) larval eye discs stained
with a-C3. Arrows in (C) mark persistence of the a-C3 signal at the lateral
margins of this disc. Bracket in (F) marks enhanced C3 expression in cells
posterior to the MF. Arrowheads indicate position of the MF.
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styD5/M(3) eyes were larger than Gap1F2.4-A3/M(3) and aosD7/
M(3) eyes (Figure 6C), indicating that the styD5 allele elicits
stronger or more varied effects on downstream growth and
survival pathways. Interestingly, compound loss of ago and
sty, Gap1, or aos did not lead to a readily detectable increase
in adult eye size beyond that observed with sty, Gap1, or aos
alone (Figure 6C). Synergy in ago,Gap1 and ago,aos eyes
might be obscured by MF-associated cell death. However,
the lack of a synergistic effect between ago1 and the styD5
allele might indicate that ago and sty regulate growth via over-
lapping mechanisms or that simultaneous loss of both genes
activates other compensatory mechanisms that reduce final
organ size.
C3 expression at the lateral margins of ago1/M(3),ey > Elp
eye discs resembles the expression pattern of the wingless
(wg) morphogen, which plays a proapoptotic role at the
margins of the late pupal eye disc [38, 39]. To test whether
this lateral C3 might require wg, we placed one copy of the
wgI-17 loss-of-function allele [40] in the ago1/M(3) background.
This strongly reduced adult eye size (Figure 6C) and elevated
rates of apoptosis among cells behind the MF (bracket in
Figure 8F). Thus, rather than engaging a Wg-dependent death
pathway, ago1 appears to sensitize cells to a Wg survival
signal that operates among differentiated cells behind the
MF. Together, these data argue that MF-associated death of
ago1 cells is driven by an autonomous mechanism requiring
de2f1 but that the strength of this signal can be modified by
signals transduced through the EGFR and RTK pathways.
Moreover, a second pathway involving wg appears to modu-
late the sensitivity of ago1 cells to death at a subsequent stage
of development behind the MF. The net growth effects of ago
mutations are thus a product of intrinsic proliferative proper-
ties and extrinsic signals that modulate rates of apoptosis
among these cells.
Discussion
Many mammalian tumor suppressors simultaneously restrict
cell proliferation and apoptosis. As a result, the oncogenic
effect of inactivating these genes is balanced by increased
apoptosis. Data presented here show that this central tenet
of vertebrate cancer biology also applies to the Drosophila
growth suppressor gene ago, a homolog of the mammalian
tumor suppressor Fbw7. Eye overgrowth resulting from loss
of ago is retarded by apoptosis that occurs as agomutant cells
encounter the MF. Blocking this death leads to eye hyper-
trophy, demonstrating that ago mutations can synergize with
antiapoptotic mutations to drive organ overgrowth. The
pattern of apoptosis in ago mutant eye discs resembles that
caused by loss of the retinoblastoma homolog rbf1 [20], and
we find that ago acts as a required inhibitor of the de2f1/rbf1
pathway in this organ. Removing de2f1 trans-activation func-
tion from ago mutant cells blocks apoptosis but does not
retard their clonal overgrowth, indicating that ago acts through
de2f1 to activate transcription of genes required for apoptosis
but not tissue growth. Together, these data link two tumor
suppressor gene homologs, ago and rbf1, in a common devel-
opmental pathway and show that the role of ago as a required
regulator of the rbf1/de2f1 pathway activity can have a signifi-
cant impact on the phenotypic outcome of ago loss.
The tissue specificity of the ago apoptotic phenotype indi-
cates that a signal associated with the MF provides a proapop-
totic cue to ago cells. Because this signal, or combination ofsignals, is not known, it is difficult to predict where and when
ago cells in other organs will die. Part of the prodeath stimulus
may come from an inability of ago cells to respond to cell-cycle
arrest pathways that begin to be activated as cells approach
the MF. However, because cells in other organs (e.g., an-
tennae) are also required to exit the cell cycle as part of their
own differentiation programs, cell-cycle exit per se does not
kill ago mutant cells. Thus, signals that are either eye specific
or MF specific, or that are associated with sharply timed
synchronous arrest (as in the zone of nonproliferating cells in
the larval wing), may also play important roles in the death of
ago cells.
rbf1 and ago mutant eye disc cells appear to share a
common apoptotic mechanism that requires intact de2f1 func-
tion and involves elevated expression of prodeath genes like
hid. However, the variable ability of EGFR pathway alleles to
rescue death of ago and rbf1 mutant cells argues that ago
loss may elicit a more complex and perhaps stronger proapop-
totic stimulus than loss of rbf1. Because studies of rbf1-regu-
lated apoptosis were performed with both hypomorphic
(rbf1120a) and null (rbf114) alleles of rbf1 [20], differences be-
tween ago and rbf1 mutant phenotypes are not easily attribut-
able to differences in allele strength. We favor a model in which
additional factors that act downstream of ago synergize with
de2f1 to provide a prodeath stimulus that is stronger than
that in rbf1 cells. de2f1 hyperactivation is still required for
death in both situations, but because of these additional pro-
death inputs, the threshold of EGFR/RTK signaling required
to rescue ago cells is only met by the ey > Elp or styD5 alleles.
The reciprocal finding that an EGFR allele shrinks ago1/M(3)
eyes supports a model in which EGFR signaling is limiting for
the survival of ago cells and suggests that the fate of individual
ago cells just anterior to the MF might depend on local varia-
tions in EGFR signaling strength in a manner similar to that
shown for rbf1 cells [20].
Based on studies showing that Fbw7 degrades the Notch
intracellular domain [7] and that Notch-1 promotes the death
of Fbw7 mutant mouse embryonic fibroblasts [41], Notch is
a candidate proapoptotic factor in ago cells. Indeed, because
Notch is antagonistic to EGFR signaling (reviewed in [42]),
elevated Notch signaling is one potential explanation for the
differential sensitivity of ago and rbf1 apoptosis to EGFR path-
way alleles. Studies that place Drosophila Notch upstream of
de2f in the larval eye disc [43] and within the MF [44, 45]
suggest that it could synergize with CycE and dMyc to elevate
de2f1 activity in ago cells. However, because CycE, dMyc, and
Notch are all proposed to have de2f1-independent roles in
cells, the differences between ago and rbf1 apoptotic pheno-
types could involve roles for ago in pathways beyond the
rbf1/de2f1 pathway.
In light of the high rates of apoptosis among ago1 eye cells, it
now appears that ago mutations were identified in mosaic
screening only because the proliferative advantage conferred
by ago loss could not be completely counterbalanced by
increased death. A similar mechanism has been postulated
to explain the relationship between ago loss and excess
numbers of interommatidial cells in the pupal eye disc [3]. If
this phenomenon can be generalized to other Drosophila anti-
growth genes, then traditional mosaic screens carried out in
the background of intact apoptotic signaling might be limited
in their ability to identify factors that simultaneously restrict
growth and apoptosis. Such genes might be more easily iden-
tified in screens designed to recover mutations that synergize
with a block in apoptosis to drive hyperplasia.
ago Limits Eye Apoptosis
1509The synergistic effect of ago and H99/hid loss on growth is
quite similar to cooperativity between alleles of mammalian
tumor suppressors like Rb and p53 (e.g., [46]). Whether
Fbw7 mutations require a collaborating block in death in order
to promote vertebrate tumorigenesis has not been carefully
examined. If so, then Drosophila may provide an excellent
system in which to identify second-site modifiers of the ago
small-eye phenotype whose vertebrate homologs are candi-
dates to modulate the rate of growth of Fbw7 mutant tumors.
Although some of these modifiers are expected to block apo-
ptosis and reverse the ago small-eye phenotype (e.g., hid),
others could increase apoptosis of ago1 cells and shrink or
ablate ago mutant organs (e.g., wg and EGFR). Thus, the fly
eye may be an ideal system in which to identify genetic or phar-
macological conditions that mimic conditions anterior to the
MF and lead to widespread apoptosis of ago mutant cells.
Such manipulations may be useful tools to induce the apo-
ptotic death of human cancer cells lacking Fwb7 function.
Experimental Procedures
Genetics
Crosses were performed at 25C. Genotypes used for cell-lethal experiments
were eyFLP;P[m-w+]RpL141,FRT80B, ago1FRT80B/TM6B, agox2,Df(3L)
H99,FRT80B/TM6B, ago1,hid05014,FRT80B/TM6B, ago1,styD5,FRT80B/
TM6B, ago1,aosD7,FRT80B/TM6B, ago1,Gap1F2.4A3,FRT80B/TM6B,EGFRt1/
CyO;ago1FRT80B/TM6B, wgxx/CyO;ago1FRT80B/TM6B, cycEAR95/CyO;
ago1FRT80B/TM6B, and ago1,FRT80B,de2f1rM729/TM6B. Genotypes used
for ago mosaic experiments were w;P[m-w+;PCNA-EmGFP];ago1,FRT80B/
TM6B, eyFLP;P[m-w+;arm-LacZ],FRT80B/TM6B, ago1,FRT80B/TM6B,
eyFLP;P[m-w+;ubi > GFP],FRT80B, eyFLP;;ubi > GFP,FRT80B,de2f1rM729,
and ago1,FRT80B,de2f1i2/TM6B. Genotypes used for transgenic expression
were UAS-rbf1/CyO:twi-GFP;ago1,FRT80B/TM6B, UAS-dap/CyO:twi-GFP;
ago1,FRT80B/TM6B, UAS-Elp/CyO:twi-GFP;ago1,FRT80B/TM6B, eyFLP;
act > y+ > Gal4;P[m-w+]RpL141,FRT80B/TM6B, w;UAS-p35;ago1,FRT80B/
TM6B, eyFLP;act > y+ > Gal4;P[m-w+,arm-LacZ],FRT80B/TM6B, UAS-
cycE, UAS-dMyc, and UAS-dp53R155H. PCNA-EmGFP was a gift of R. Duro-
nio, and UAS-Elp and EGFRt1 were gifts of A. Mortimer. de2f1rM729, de2f1i2,
and wgl-17 were obtained from the Bloomington Drosophila Stock Center.
styD5 and aosD7 were gifts of N. Moon and I. Rebay.
Eye Measurements
Eye and wings were photographed with a Leica DFC500 charge-coupled
device digital camera, and sizes were quantitated with Adobe Photoshop.
A minimum of ten eyes and wings were measured per genotype.
Immunohistochemistry and Microscopy
Immunostaining and confocal microscopy were performed as described
previously [4]. Antibodies used were rabbit anti-cleaved caspase-3 (Cell
Signaling, 1:100); rat anti-Elav (Developmental Studies Hybridoma Bank,
1:200); guinea pig anti-dE2f1 (T. Orr-Weaver, 1:1000); rabbit anti-GFP
(Molecular Probes, 1:1000); mouse anti-b-gal (Promega, 1:1000); rabbit
anti-Hid (H. Steller, 1:2500); rabbit anti-Reaper (S. Kornbluth, 1:1000). Scan-
ning electron microscopy was performed by the Apkarian Integrated Elec-
tron Microscopy Core (Emory University) with a Topcon DS-130F field emis-
sion scanning electron microscope.
Real-Time Reverse Transcriptase-PCR
Total RNA isolated from 30 eye discs (TRIzol, Invitrogen) was reverse tran-
scribed (SuperScript II RT, Invitrogen) and analyzed by quantitative PCR
(SYBR Green 1 Master Mix, Roche). Primers used were hid, 50-GTGGAGC
GAGAACGACAAA-30 and 50-TTGGCCAAGTGAAGCTCTGT-30; rpr 50-TCGA
TTTCTACTGCAGTCAAGG-30 and 50GAGTAAACTAAAATTGGGTGGGTGT-30;
and b-tub, 50-CGCACAGAGTCCATGGTG-30 and 50-AAATCGTTCACATC
CAAGCTG-30.
Cell Culture
S2 cells were cultured under standard conditions. dsRNA interference was
carried out as described previously [47]. Reporter experiments were per-
formed in triplicates in two separate experiments. Briefly, cells were pre-
treated with dsRNA for 4 days, transfected with PCNA-luc and pIE4-lacZplasmids (Cellfectin, Invitrogen), and analyzed 48 hr later. Error bars repre-
sent the standard deviation of the mean.
Supplemental Data
Supplemental Data include five figures and can be found with this
article online at http://www.cell.com/current-biology/supplemental/
S0960-9822(09)01547-4.
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